Detection of circulating tumor cells (CTCs) has been made to develop reliable assays for early diagnosis of various cancers. Overexpression of survivin in cancer cells is strongly associated with tumor progression.
Although upregulation of survivin is observed in various tumors, its expression profile in the peripheral blood of prostate cancer (PCa) patients has not yet been investigated. In this study, we validated the application of survivin as the tumor marker to detect CTC and assessed its utility for diagnosis of PCa distant metastasis. Immunohistochemistry and quantitative real-time PCR (QRT-PCR) were performed to confirm the levels of surviving expression in PCa tissues. In addition, CTC values in 3 mL of peripheral blood from PCa patients, benign prostate hyperplasia (BPH) patients, and normal controls were also measured by the survivin-targeted PCR. Our results showed that surviving was overexpressed in PCa tissues. The median levels of blood surviving mRNA of PCa patients, BPH patients, and normal controls were 5. 67 (range from 0 to 12. 46), 2. 24 (range from 0 to 6. 55), and 1. 85 (range from 0 to 3. 82), respectively. The levels of survivin are positively associated with PCa distant metastasis. Our results concluded that quantitation of CTCs through survivin-PCR could be a promising marker for diagnosis of PCa metastasis.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2015 Aug 06 [Epub ahead of print]
Huansheng Wang, Mingshan Yang, Jian Xu, Benkui Zou, Qian Zhou, Jiasheng Bian, Xingwu Wang
Department of Urology Surgery, Shandong Cancer Hospital, No. 440 Jiyan Road, Jinan, Shandong, 250117, People's Republic of China